中文名 | UTL-5g |
英文名 | UTL-5g |
英文别名 | 3-Isoxazolecarboxamide, N-(2,4-dichlorophenyl)-5-methyl- |
CAS | 646530-37-2 |
化学式 | C11H8Cl2N2O2 |
分子量 | 271.1 |
密度 | 1.469±0.06 g/cm3(Predicted) |
沸点 | 336.2±42.0 °C(Predicted) |
酸度系数 | 9.45±0.70(Predicted) |
存储条件 | -20℃ |
体外研究 | RAW 264.7 macrophages are transfected with the respective reporter assay plasmids, pretreated with UTL-5g at 1, 10 or 50 µM for 60 min and then challenged with 100 ng/ml LPS. After a 16 h incubation, transcription factor activity is measured. Transcription factors that shows a UTL-5g dose-dependent decrease in activity in two experiments are categorized as being disrupted by UTL-5g. |
体内研究 | UTL-5g (GBL-5g) lowers levels of TGF-β and TNF-α elevated by lung irradiation. UTL-5g (60 mg/kg; p.o.; daily for 4 days) shows positive effects in increasing the survival rates and extending the survival times. Animal Model: C57BL/6, male mice (8-10 weeks) Dosage: 15, 30, and 60 mg/kg Administration: I.p.; before irradiation, daily x 5 Result: Blood levels of TGF-β were lowered. Animal Model: BDF1 female mice Dosage: P.o.; daily for 4 days Administration: 60 mg/kg (30 min before i.p. injection of Cisplatin at 10, 15, and 20 mg/kg respectively on Day 0) Result: Increased the survival rate and delayed the time to death for mice treated with 150% of the maximum tolerated dose (MTD) of Cisplatin (15 mg/kg). At 200% of the MTD of Cisplatin (20 mg/kg), treatment of UTL-5g increased the survival rate and delayed the time to death. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 3.689 ml | 18.443 ml | 36.887 ml |
5 mM | 0.738 ml | 3.689 ml | 7.377 ml |
10 mM | 0.369 ml | 1.844 ml | 3.689 ml |
5 mM | 0.074 ml | 0.369 ml | 0.738 ml |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!